Leeward Financial Partners LLC Acquires 10,550 Shares of UnitedHealth Group Incorporated $UNH

Leeward Financial Partners LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1,115.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 11,496 shares of the healthcare conglomerate’s stock after purchasing an additional 10,550 shares during the period. Leeward Financial Partners LLC’s holdings in UnitedHealth Group were worth $3,586,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in UNH. Nuveen LLC bought a new position in shares of UnitedHealth Group in the first quarter worth about $3,846,764,000. Vanguard Group Inc. increased its stake in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its stake in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. National Bank of Canada FI increased its stake in UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after acquiring an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts recently issued reports on UNH shares. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Wells Fargo & Company upped their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. TD Cowen upped their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday. Oppenheimer lowered their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, UBS Group increased their price target on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 1.0%

NYSE:UNH opened at $341.46 on Friday. The stock’s fifty day moving average price is $343.51 and its two-hundred day moving average price is $329.40. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The company has a market cap of $309.25 billion, a price-to-earnings ratio of 17.82, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $7.15 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 46.14%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.